Postvaccination increase in serotype 19A pneumococcal disease in Norway is driven by expansion of penicillin-susceptible strains of the ST199 complex

Clinical and Vaccine Immunology

Volumn 19, Issue 3, 2012, Pages 443-445

  Vestrheim, Didrik F ^a   Steinbakk, Martin ^a   Aaberge, Ingeborg S ^a   Caugant, Dominique A ^a,b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

AGE DISTRIBUTION; ARTICLE; BACTERIAL STRAIN; CHILD; HUMAN; INCIDENCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NORWAY; PENICILLIN RESISTANCE; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; STRAIN IDENTIFICATION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PNEUMONIAE SEROTYPE 19A;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; HUMANS; MICROBIAL SENSITIVITY TESTS; NORWAY; PENICILLINS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 84857928227     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05563-11     Document Type: Article

References (17)

1. 14-230 clone as an increasing cause of pneumococcal infection in Portugal within a background of diverse serotype 19A lineages. J. Clin. Microbiol. 48:101-108.
2. Beall BW, et al. 2011. Shifting genetic structure of invasive serotype 19A pneumococci in the United States. J. Infect. Dis. 203:1360-1368.
3. Choi EH, et al. 2008. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg. Infect. Dis. 14:275-281.
4. Dagan R, Givon-Lavi N, Leibovitz E, Greenberg D, Porat N. 2009. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J. Infect. Dis. 199:776-785.
5. Enright MC, Spratt BG. 1998. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049-3060. (Pubitemid 28515583)
6. Goossens H, Ferech M, Coenen S, Stephens P, and European Surveillance of Antimicrobial Consumption Project Group. 2007. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin. Infect. Dis. 44:1091-1095. (Pubitemid 46580279)
7. Hicks LA, et al. 2007. Incidence of pneumococcal disease due to nonpneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J. Infect. Dis. 196:1346-1354. (Pubitemid 351412007)
8. Mahjoub-Messai F, et al. 2009. Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of sevenvalent pneumococcal vaccination for French children. J. Clin. Microbiol. 47:837-840.
9. Marimón JM, et al. 8 September 2011, posting date. Molecular characterization of Streptococcus pneumoniae invasive serotype 19A isolates from adults in two Spanish regions (1994-2009). Eur. J. Clin. Microbiol. Infect. Dis. doi:10.1007/s10096-011-1399-3.
10. Miller E, Andrews NJ, Waight PA, Slack MP, George RC. 2011. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect. Dis. 11:760-768.
11. Moore MR, et al. 2008. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J. Infect. Dis. 197: 1016-1027. (Pubitemid 351590031)
12. NORM/NORM-VET. 2011. NORM/NORM-VET 2010. Usage of antimicrobial agents and occurrence of antimicrobial resistance in Norway. NORM/NORM-VET, Tromsø, Norway.
13. Pai R, et al. 2005. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States. J. Infect. Dis. 192:1988-1995. (Pubitemid 41681898)
14. Pilishvili T, et al. 2010. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J. Infect. Dis. 201:32-41.
15. Vestrheim DF, et al. 2010. Indirect effect of conjugate pneumococcal vaccination in a 2+1 dose schedule. Vaccine 28:2214-2221.
16. Vestrheim DF, Høiby EA, Aaberge IS, Caugant DA. 2010. Impact of a pneumococcal conjugate vaccination program on carriage among children in Norway. Clin. Vaccine Immunol. 17:325-334.
17. Vestrheim DF, et al. 2008. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine 26:3277-3281.